Connect with us

Technology

Nanoscope Therapeutics Appoints Gene Therapy Operations Leader Troy Short as Senior Vice President, Manufacturing and Supply Chain

Published

1 hour ago

on

Operations and supply chain executive with more than 20 years of experience spanning GMP manufacturing, global clinical and commercial supply, and gene therapy launch executionFormer VP of Global Supply Chain and interim Chief Technical Officer at AveXis, where he built and led the global supply chain organization through the launch of Zolgensma® across more than 30 countriesAppointment strengthens manufacturing and supply chain leadership as Nanoscope advances lead product MOGENRY™ through regulatory review toward potential global commercialization

DALLAS, Oct. 14, 2026 /PRNewswire/ — Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor loss and vision impairment due to retinal degeneration, today announced the appointment of Troy Short as Senior Vice President, Manufacturing and Supply Chain. In this role, Short will lead Nanoscope’s GMP manufacturing, commercial supply, and global distribution strategy as the company advances toward the potential approval and launch of MOGENRY™ (sonpiretigene isteparvovec; MCO-010).

Mr. Short brings more than two decades of operations and supply chain leadership across the pharmaceutical and gene therapy industries, with particular depth in building the manufacturing and distribution capabilities required to bring genetic medicines to patients. He previously served as Vice President of Global Supply Chain at AveXis, Inc., where he built and led the global commercial supply chain organization through the launch of Zolgensma®, scaling distribution globally, including the design of the specialized cold-chain model required for patient-specific delivery. He negotiated supply agreements, managed raw material sourcing, led the enterprise resource planning system implementation, and played a leadership role in FDA licensure and commercial readiness. Following the acquisition of AveXis by Novartis, he served as interim Chief Technical Officer during the transition.

Mr. Short subsequently served as Senior Vice President of Manufacturing and Supply Chain at Jaguar Gene Therapy, where he built Jaguar’s CMC and supply chain organization, internalized process and analytical development, and directed the design of their GMP manufacturing facility. He later served as Chief Operating Officer of Advanced Medicine Partners, leading the design and startup of their GMP facility. Most recently, through his firm GTxConsulting, he has advised biotechnology companies and investment firms on CMC strategy, as well as supply chain and BLA readiness for gene therapies and other advanced modalities. Earlier in his career, Mr. Short spent 11 years at Hospira, a Pfizer company, as Director of Supply Chain for sterile pharmaceutical manufacturing.

“Troy has done what very few people in our industry have done: built and run the supply chain that delivered an approved AAV gene therapy to patients around the world,” said Sulagna Bhattacharya, Co-Founder and Chief Executive Officer of Nanoscope Therapeutics. “A one-time intravitreal therapy manufactured in the U.S. has to reach every patient who needs it, at quality, without interruption. That capability is built years in advance, and Troy knows exactly how to execute. His arrival at this stage reflects how seriously we are taking our preparation for launch.”

Nanoscope continues to build clinical, regulatory, scaled-up manufacturing, and commercial-preparation momentum in support of MOGENRY for inherited retinal dystrophies (IRDs). The U.S. Food and Drug Administration (FDA) has accepted and filed the company’s Biologics License Application (BLA) for MOGENRY for the treatment of retinitis pigmentosa (RP) with severe vision loss. The BLA is presently under FDA review. A Japan New Drug Application (JNDA) for MOGENRY is also currently under PMDA review for IRDs. These milestones reflect the company’s expanding international regulatory pathway as it advances commercialization planning across key global markets.

“MOGENRY is designed to work regardless of the gene behind a patient’s vision loss. My job is to make sure it reaches them,” said Short. “My focus will be on strengthening our manufacturing partnerships, building a resilient commercial supply chain, and making sure patients and their physicians can count on product availability upon its potential approval.” 

About Inherited Retinal Dystrophies
Inherited retinal dystrophies (IRDs) are a genetically diverse group of rare disorders, caused by mutations in more than 250 genes, in which progressive loss of photoreceptor cells leads to impaired vision and, in most cases, complete blindness. IRDs include retinitis pigmentosa, the most common IRD, as well as Stargardt disease, cone-rod dystrophies, and Leber congenital amaurosis, among others. Because gene-specific therapies address only a single genetic cause, the vast majority of patients with IRDs have no approved treatment option.

About MOGENRY (sonpiretigene isteparvovec; MCO-010)
Nanoscope’s multi-characteristic opsin (MCO) technology utilizes a proprietary genetically engineered synthetic opsin to enable optimized performance in terms of high light sensitivity across a broad spectrum and fast kinetics. After Nanoscope’s Co-Founder, President, and Chief Scientific Officer, Samarendra Mohanty, envisioned and invented the technology, his team spent more than a decade evaluating its performance across multiple animal models and human diseases. MOGENRY is an investigational, one-time, in-office, intravitreal optogenetic gene therapy built on Nanoscope’s MCO platform. By delivering a multi-characteristic opsin gene to the highly dense bipolar retinal cells, MOGENRY makes these surviving cells directly light-sensitive, enabling them to utilize the remaining visual circuitry following photoreceptor loss. MOGENRY does not require genetic testing, invasive surgery, or repeat dosing, and is designed for administration within existing retina office workflows.

About Nanoscope Therapeutics
Nanoscope Therapeutics is developing disease-agnostic, vision-restoring optogenetic therapy for millions of patients blinded by retinal degenerative diseases. Following positive results from the RESTORE Phase 2b/3 multicenter, randomized, double-masked, sham-controlled clinical trial for RP (NCT04945772), the FDA has accepted and filed the company’s BLA for MOGENRY, and the PMDA has accepted for priority review the company’s Japan new drug application (JNDA) for MOGENRY for the treatment of IRDs. If approved, MOGENRY has the potential to become the standard of care for patients with RP and other IRDs, administered as a one-time, in-office injection without the need for genetic testing. The company has also shown promising results in the STARLIGHT Phase 2 clinical trial (NCT05417126) of MCO-010 in Stargardt disease (SD) and plans to initiate a Phase 3 registrational trial in 2026. MCO-010 has received FDA Fast Track and Orphan Drug designations for both RP and SD, along with Regenerative Medicine Advanced Therapy (RMAT) designation for SD, and European Medicines Agency (EMA) Orphan designations covering non-syndromic and syndromic rod- and cone-dominant dystrophies, as well as macular dystrophies. MCO-010 has also received Sakigake and Orphan designations for IRDs in Japan and an Orphan designation for IRDs in Saudi Arabia. A Phase 2 program for MCO in geographic atrophy is expected to start in 2026, and other investigational new drug (IND)-ready programs include Leber congenital amaurosis (LCA). Learn more at NanosTherapeutics.com and follow @NSTherapeutics on X and on LinkedIn. 

Contact:
Nanoscope Therapeutics Inc.
+1 (817) 857-1186
PR@nanostherapeutics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/nanoscope-therapeutics-appoints-gene-therapy-operations-leader-troy-short-as-senior-vice-president-manufacturing-and-supply-chain-302908069.html

SOURCE Nanoscope Therapeutics

Related Topics:
Continue Reading

Technology

LG Electronics Accelerates GCC Growth Trajectory with Strategic Partnership in Kuwait

Published

12 minutes ago

on

October 14, 2026

By

Global tech leader reinforces regional commitment, introducing full consumer, commercial, and HVAC portfolios alongside new immersive experience and service hubs.

News Summary

LG Electronics collaborates with Al Mulla Group to strengthen its market presence and distribution capabilities in Kuwait.The agreement enhances access to LG’s complete ecosystem of Consumer Electronics, enterprise Business Solutions, and Commercial HVAC systems.An integrated facility featuring an immersive LG Experience Center and global-standard service center is scheduled to open in 2027.The agreement was signed in Kuwait alongside LG MEA leadership and Al Mulla Group executives.

KUWAIT CITY, Oct. 14, 2026 /PRNewswire/ — LG Electronics (LG) today announced a strategic distribution agreement with Al Mulla Group to strengthen its market presence and enhance product availability across Kuwait, reinforcing the brand’s long-standing commitment to local consumers and the wider GCC region.

The initiative aligns with LG’s commitment to driving regional growth across the GCC by bringing its complete, end-to-end technology ecosystem – spanning cutting-edge consumer electronics, business solutions, and commercial air conditioning – closer to regional consumers and commercial clients.

Under the strategic agreement, subsidiary Al Mulla Electronics will serve as an authorised distributor in Kuwait for LG, leveraging robust local infrastructure and market reach to deliver LG’s full product lineup. This includes premium OLED and QNED displays, AI-enabled home appliances, laptops and monitors, state-of-the-art digital signage and commercial display solutions, as well as high-efficiency commercial HVAC technologies including VRF systems, chillers, and building management solutions.

The agreement was signed during a ceremony at Al Mulla Group’s headquarters in Kuwait. The event was attended by Mr. Phil Won Jung, Regional CEO of LG Electronics Middle East & Africa, alongside Mr. Talal A. Al Mulla, Board Member and CEO of Al Mulla Group, as well as Mr. Elie Zoghb, Managing Director of Trading & Manufacturing and Rental & Leasing at Al Mulla Group.

Highlighting LG’s long-term vision for the region, Mr. Young Hak Jeong, Managing Director, LG Electronics Gulf, stated: “The GCC region represents a key growth driver in LG’s global strategy. As demand continues to surge across the Middle East for intelligent, energy-efficient, and connected living environments, our strategic expansion in Kuwait reinforces our commitment to bringing meaningful innovations to the region. Partnering with a respected market leader like Al Mulla Group provides the strong operational foundation needed to deliver the full breadth of LG’s technological expertise – supported by world-class local service standards and immersive retail experiences.”

To further enhance the brand experience for consumers and business partners, the partnership includes the development of an integrated, state-of-the-art facility scheduled to launch in 2027. The project will feature a flagship LG Experience Center, designed to offer an immersive, interactive environment showcasing LG technologies within realistic residential and commercial settings. The hub will also house a dedicated after-sales service center built to LG’s global standards, ensuring an elevated customer experience across the product lifecycle.

With this milestone, LG continues to consolidate its leadership position across key Middle Eastern markets, accelerating digital transformation and enriching customer experiences through tailored consumer and enterprise solutions.

About LG Electronics, Inc. 

LG Electronics is a global innovator in technology and consumer electronics with a presence in almost every country and an international workforce of more than 75,000. LG’s four Companies – Home Appliance Solution, Media Entertainment Solution, Vehicle Solution and Eco Solution – combined for global revenue of over KRW 89 trillion in 2025. LG is a leading manufacturer of consumer and commercial products ranging from TVs, home appliances, air solutions, monitors, automotive components and solutions, and its premium LG SIGNATURE and intelligent LG ThinQ brands are familiar names world over. Visit www.LG.com/global/newsroom/ for the latest news. 

 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/lg-electronics-accelerates-gcc-growth-trajectory-with-strategic-partnership-in-kuwait-302908443.html

Continue Reading

Technology

PEGATRON Brings AI Infrastructure from Design to Deployment at OCP Global Summit 2026

Published

12 minutes ago

on

October 14, 2026

By

SAN JOSE, Calif., Oct. 14, 2026 /PRNewswire/ — PEGATRON, a globally recognized provider of comprehensive AI infrastructure and server solutions, will showcase its capabilities in developing and manufacturing next-generation AI infrastructure at OCP Global Summit 2026. Under the theme “Scaling Innovation for the AI Era,” Pegatron will demonstrate how advanced AI platforms can be transformed into production-ready systems, racks, and clusters for rapid deployment in data centers.

As AI infrastructure scales from individual servers to large-scale clusters, successful deployment requires more than compute performance. It requires system-level engineering, liquid cooling, power architecture, open standards, manufacturing readiness, and rigorous validation. Pegatron brings these capabilities together through OCP-aligned architectures, including ORv3 busbar, DC-MHS, and OCP 3.0 network adapters, enabling modular and scalable infrastructure for modern data centers. Its OCP-compliant platforms span AI rack solutions, accelerated computing, compute, and storage infrastructure.

At the center of the showcase is the NVIDIA Vera Rubin NVL72, Pegatron’s RA4803-72N3, a rack-scale AI platform integrating 72 NVIDIA Rubin GPUs, 36 NVIDIA Vera CPUs, 6th generation NVIDIA NVLink, and fully liquid-cooled rack-level integration. The platform highlights Pegatron’s ability to engineer and manufacture complex rack-scale AI solutions and migrate from design to cluster deployment.

Extending beyond accelerated computing, Pegatron will showcase a NVIDIA Vera CPU liquid-cooled system and NVIDIA Groq 3 LPX, addressing the evolving infrastructure requirements of agentic AI. NVIDIA Vera, the CPU for agents, is optimized to execute tool calls, sandboxed code, and reinforcement-learning loops between model steps. Deployed at rack scale, NVIDIA Vera CPU provides dense capacity to run alongside GPU infrastructure, supporting efficient execution, orchestration, and data processing workloads in AI factories. NVIDIA Groq 3 LPX further extends the NVIDIA Vera Rubin platform for highly interactive, latency-sensitive inference.

Pegatron will also feature the AS210-2T1-8H3, a 2U fully liquid-cooled NVIDIA HGX Rubin NVL8 system combining dual Intel® Xeon® 6 processors, AMD EPYC™ 9006 processors, or NVIDIA Vera CPUs with an eight NVIDIA Rubin GPU baseboard. The platform demonstrates high-density system engineering, fully liquid-cooled architecture, and rack-level integration. Its rack-scale configurations include the RA4800-64H3, supporting eight systems and up to 64 GPUs, and the RA4800-72H3, supporting nine systems and up to 72 GPUs in a 48U liquid-cooled rack.

The portfolio also includes AI-ready compute and storage infrastructure powered by AMD EPYC™ 9006 Series processors. Pegatron will showcase the SS201-1A1, a 2U single-socket storage server supporting up to 32 E3.S NVMe SSDs for high-throughput AI data pipelines, alongside the GS203-2A2 and GS205-2A2E 2U dual-socket platforms for enterprise, cloud, HPC, and data-intensive workloads. With up to 256 cores and 512 threads, high memory bandwidth, and PCIe® Gen 6 connectivity, AMD EPYC 9006 processors provide a high-density compute foundation across compute and storage applications. These platforms incorporate OCP 3.0, DC-MHS, and flexible power architectures, including 48VDC busbar configurations for OCP racks.

From digital engineering to factory deployment, Pegatron is extending its AI infrastructure capabilities through NVIDIA DSX AI factory platform-aligned workflows. At its facilities, digital-twin simulation and optimization are connected with physical manufacturing, automated production, thermal validation, and system to rack level run-in testing, helping translate engineering insights into production-ready AI infrastructure.

“A key measure of AI infrastructure is how efficiently it can move from engineering to deployment,” said Gary Cheng, President and Co-CEO of Pegatron. “Pegatron combines deep system design expertise with vertically integrated manufacturing, OCP-aligned architecture, and rack-level validation before deployment to rapidly build and deploy AI servers, clusters, and data center infrastructure at scale. By connecting digital-twin simulation, thermal validation, automated manufacturing, and rack-level testing, we help customers move faster from AI infrastructure design to production deployment.”

Through its integrated capabilities, Pegatron is enabling AI infrastructure to move beyond individual systems toward production-ready AI clusters and data centers—bringing advanced AI infrastructure from concept and simulation to validated, scalable deployment.

For more information, please visit PEGATRON SVR website and follow us on LinkedIn and YouTube.
Website: https://svr.pegatroncorp.com  
LinkedIn: https://tw.linkedin.com/showcase/pegatron-svr/
YouTube: https://www.youtube.com/@PEGATRONSVR 

About PEGATRON

PEGATRON Corporation (hereafter referred to as “PEGATRON”), with abundant product development experience and vertically integrated manufacturing, is committed to providing clients with innovative design, systematic production, and manufacturing services to comprehensively and efficiently satisfy all our customers’ needs.

Drawing on accumulated experience in server design, manufacturing, and deployment, Pegatron focuses on developing a variety of state-of-the-art servers including liquid-cooled/air-cooled server solutions based on x86 and ARM architectures, racks, and AI clusters, that meet the requirements of present and future Cloud Service Providers’ data centers, as well as enterprise-grade data centers.

Pegatron Corporation Website: https://www.pegatroncorp.com/  

View original content to download multimedia:https://www.prnewswire.com/news-releases/pegatron-brings-ai-infrastructure-from-design-to-deployment-at-ocp-global-summit-2026-302908444.html

SOURCE PEGATRON CORPORATION

Continue Reading

Technology

A $2.1 Trillion Wellness Industry Never Built a Daily Practice for Black Children. So This Atlanta Family Did.

Published

12 minutes ago

on

October 14, 2026

By

Bright Crowns, the first daily wellness practice made for Black children, delivers a five-minute morning routine backed by decades of research to help them walk into any room certain of who they are and ready to reach for more.

ATLANTA, Oct. 14, 2026 /PRNewswire/ — Bright Crowns, the first daily wellness practice built specifically for Black children, is now available on the Apple App Store. Its five-minute morning routine is designed to build resilience, identity and confidence before children walk out the door.

Breath, affirmation, and the example of inspiring Black figures, past and present, move together as one. Their courage, brilliance, and resolve are reflected back as strengths the child already carries. It’s a complete wellness session, made to strengthen a child from the inside out. Throughout those five minutes, a child settles, remembers who they are and where they come from, and leaves steadier and grounded in their own worth. The arc is deliberate: Breathe. Belong. Become.

It doesn’t end with the morning. Bright Crowns moves with a child from morning to night: boosting confidence before a test or a game, settling a big feeling the moment it rises, winding down at night with sleep stories from the African diaspora, and closing the week with a reflection a parent reads aloud to their child, to set the tone for the days ahead. Children earn crowns drawn from real African kingdoms, an inheritance rather than a reward. The point isn’t making a child feel better for five minutes; it’s giving them tools that compound: steadiness, identity and resilience they carry long after the session ends, and the belief that a brighter future is theirs to reach.

Husband-and-wife team David and Tia Harley, Atlanta parents of two young kids, built Bright Crowns for their own children after searching a $2.1 trillion wellness industry and finding only generic apps: polished and useful, but spoken in voices and settings that never felt like home, and asking a Black child to set part of themselves aside just to belong there. The couple each brought more than two decades of professional experience to a labor of love. David is an award-winning creative director who has led multicultural brand campaigns; Tia led business development and partnerships at Google after a marketing career at AT&T. They used Bright Crowns with their own children every morning for more than a year before sharing it with other families. Over that year, they watched their children grow: quicker to recover from tough moments, more willing to try hard things, holding their heads higher. And it showed up where parents care about it most: at school, where their kids became more engaged and their grades improved.

The approach draws on decades of research. A landmark study in the journal Science found that a brief, culturally grounded practice measurably narrowed the racial achievement gap for Black students, without any change to the school itself. Research has since identified ethnic-racial identity as a key protective factor for Black youth mental health in the Annual Review of Clinical Psychology, and a meta-analysis of 76 mindfulness programs for young people found significant improvements in stress, attention, emotional regulation and academic engagement.

“We can’t always lighten the load our children carry,” said co-founder and CEO Tia Harley. “But we can help make them strong enough to carry it, with their heads held high.”

“Our children are already brilliant,” added co-founder and chief product officer David Harley. “We don’t teach them to survive. We teach them they were born to thrive. Their crowns are already on. We just help them remember.”

Bright Crowns is available now on the Apple App Store with a free seven-day trial. Families who join by Dec. 31 lock in the Founding Family rate of $69.99 for the first year; one subscription covers every child in the home. Learn more at https://hellobrightcrowns.com.

About Bright Crowns
Bright Crowns is a five-minute daily wellness practice built for Black children, and the first daily practice of its kind, available now on the Apple App Store. Founded by husband-and-wife team David and Tia Harley, who built it for their own children first, it’s grounded in decades of research on identity, mindfulness and resilience. Bright Crowns helps Black children feel steady in themselves, certain of who they are, and ready to show the world what they’re made of. Learn more at https://hellobrightcrowns.com.

Digital Press Kit:https://hellobrightcrowns.com/press

View original content to download multimedia:https://www.prnewswire.com/news-releases/a-2-1-trillion-wellness-industry-never-built-a-daily-practice-for-black-children-so-this-atlanta-family-did-302907822.html

SOURCE Bright Crowns LLC

Continue Reading

Trending